ArticleJournal of natural medicines2026
Xylocargranosides A‒B and Xylocargranin a from the Mangrove Xylocarpus granatum.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ceramaximin A and B, two bromotyrosine derivatives from the worm snail Ceraesignum maximum and their cytotoxic activity.Journal of natural medicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Xylocargranosides A–B (1–2) and xylocargranin A (3), three previously undescribed compounds, along with twelve known metabolites (4–15), were isolated from the leaves of Xylocarpus granatum. The structures and absolute configurations of the new compounds were elucidated through detailed analyses of HRESIMS and NMR spectra, corroborated by quantum chemical calculations of NMR chemical shifts and ECD spectra. Notably, compound 1 was identified as a rare 25,26,27-trinor-apotirucallane-type triterpenoid glucoside, distinguished by an uncommon side chain forming a δ-lactone moiety. The cytotoxic activities of all isolated compounds were evaluated against the A549, MCF7, and HepG2 cell lines.
Indexed as
Identifiers
41714464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.